VM202

BIOLOGICAL4 trials

Sponsors

Helixmith Co., Ltd., Northwestern University

Conditions

Amyotrophic Lateral SclerosisMyocardial IschemiaPainful Diabetic Peripheral NeuropathyPeripheral Artery Disease

Phase 1

Gene Therapy for the Treatment of Chronic Stable Angina

WithdrawnNCT01002495

Helixmith Co., Ltd.Myocardial Ischemia

Start: 2015-03-31End: 2016-01-31Updated: 2025-09-25

Gene Therapy for Painful Diabetic Neuropathy

CompletedNCT01002235

Helixmith Co., Ltd.Painful Diabetic Peripheral Neuropathy

Start: 2010-02-28End: 2012-04-30Updated: 2025-10-06

Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis

CompletedNCT02039401

Helixmith Co., Ltd.Amyotrophic Lateral Sclerosis

Start: 2014-03-11End: 2024-03-06Updated: 2025-10-06

Phase 2

Hepatocyte Growth Factor to Improve Functioning in PAD

CompletedNCT03363165

Northwestern UniversityPeripheral Artery Disease

Start: 2018-01-01End: 2023-09-05Updated: 2024-05-30